Introduction
Expression of immunoglubulin (Ig) chains is a definitive marker of B cell origin. Ig chains are generated during B cell maturation by somatic rearrangement of Ig genes. This rearrangement generally follows an orderly progression beginning with heavy (H) chain genes and proceeding to light (L) chain genes. [1] [2] [3] [4] The fact that Ig expression in B cells generally reveals single L chain and H chains implies monoclonal cell expansion. Nevertheless, several exceptions have been reported including double light chain positive cases. [5] [6] [7] [8] There have also been several reports of the isolation of double light chain positive cells from Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines derived from healthy human subjects. However, Ig negative mature B cell malignancies, excepting multiple myeloma, are unknown. We have previously reported several clones with varying Ig expression, isolated from parental cell lines by limiting dilution. 9 None of the Ig chains were detected in the 
Case report
A 42-year-old Japanese male was referred to us on 19 June 1996, with a diagnosis of relapsing B-ALL. On physical examination, mild hepatomegaly and small lymph nodes of the cervical region were noted. Hemoglobin was 10.7 g/dl, white blood cell count 19.4 × 10 9 /l with lymphoblasts 0.97 × 10 9 /l and platelets 24 × 10 9 /l. Serum creatinine was 0.14 mmol/l (0.07-0.11), albumin 40 g/l (35-50), calcium 5.35 mmol/l (2.20-2.55), phosphorus 1.55 mmol/l (0.81-1.45) and serum alkaline phosphatase 474 IU (100-340). Serum and urine electrophoresis showed no evidence of a paraprotein. The skeletal radiographs, computerized tomograms, magnetic resonance images of vertebrae, and bone scintigrams all showed normal findings. The 25-hydroxyvitamin D (25-OH-D) and 1,25-dihydroxyvitamine D (1,25-(OH)2-D) levels were 7 ng/ml (10-55) and Ͻ5 pg/ml (20-60), respectively. His intact parathyroid hormone (PTH) level was 6 pg/ml (15-50). The level of parathyroid hormone-related peptide (PTHrP) was significantly elevated at 3.8 pmol/l (Ͻ0.6). The levels of other recognized bone resorption-stimulating substances including interleukin-1␣ (IL-1␣), IL-1␤, prostaglandin E 2 , tumor necrosis factor-␣ (TNF-␣) and TNF-␤, were all within normal limits. He was seronegative for HTLV-I, and the viral genome was not detectable by the polymerase chain reaction (PCR).
A bone marrow aspirate showed 97% peroxidase-negative lymphoblasts of the L3 type. The karyotype of bone marrow cells was: 47, XY, t(1;4)(q32; q35), t(8;22)(q24;q11), t(17;20)(p12;p11), +18 in 4/20 and 46, XY in 16/20 metaphases analyzed. The hypercalcemia and associated renal impairment were successfully treated with a single dose of 45 mg pamidronate disodium in combination with intravenous fluids. The corrected serum calcium and creatinine levels decreased to 2.72 mmol/l and 0.11 mmol/l, respectively. A reinduction therapy consisting of cytarabine, etoposide, vincristine, vinblastine and l-asparaginase resulted in a remission of leukemia, during which time serially determined circulating PTHrP levels ranged between 0.2 and 0.3 pmol/l. Four weeks later, he relapsed again with a white blood cell count of 43.4 × 10 9 /l with 32.6 × 10 9 lymphoblasts/l. Serum calcium level and PTHrP level in plasma increased to 3.63 mmol/l and 7.5 pmol/l, respectively. He died of refractory ALL on 25 September 1996.
Materials and methods

Cell culture
On 8 August 1996, informed consent for diagnostic procedure was obtained, and a peripheral blood sample was taken. Wright-Giemsa staining and myeloperoxidase-staining is depicted in Figure 1a and b. Mononuclear cells from the heparinized blood were separated by Ficoll-Hypaque density gradient centrifugation. After completing the diagnostic procedure, the remaining cells were placed in a plastic culture flask (Iwaki Glass, Tokyo, Japan) containing RPMI 1640 medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented wih 10% heat-inactivated fetal bovine serum (FBS; Gibco Oriental, Tokyo, Japan), 100 U/ml of penicillin and 50 g/ml of streptomycin without additional growth factors, and incubated at 37°C in a humidified 5% CO 2 atmosphere. The culture was fed once or twice a week by replacing .-/ of the volume of the culture with fresh nutrient medium during the subsequent 2 weeks. In the third week, a slow yet sustained proliferation of cultured cells was noted, which was designated, BALM-16. Growth characteristics of the cell line were evaluated from cell growth curves. The established cell line was found to be free of mycoplasma infection by standard broth-agar cultivation and PCR methods.
Morphological studies
Cytospin smears of the established cell line, stained with Wright-Giemsa, were used for cytochemical myeloperoxidase staining. 
Immunophenotyping
Immunophenotyping of fresh leukemic blasts from the peripheral blood was performed using the following antibodies: fluorescein isothiocyanate (FITC)-conjugated goat anti-human Ig chains specific to and L chains and to ␣, ␦, ␥ and H chains (Cappel Laboratories, West Chester, PA, USA), rabbit anti-terminal deoxynucleotidyl transferase (TdT) (P-L Biochemicals, Milwaukee, WI, USA), monoclonal antibodies (mAbs) NU-T3 (CD3), NU-Th/i (CD4), NU-Tpan (CD5), NUTs/c (CD8), NU-N1 (CD10), CD11a (SPV-L7), CD13 (MCS-2), NU-B2 (CD20), H107 (CD23), KOLT-2 (CD28), NU-B1, NUla for HLA-class II (Nichirei, Tokyo, Japan); B4 (CD19), B2 (CD21), MY9 (CD33), MY10 (CD34) and HNK-1 (CD56) (Coulter Immunology, Hialeah, FL, USA); Leu-7 (CD57), Leu-M3 (CD14), Leu-M1 (CD15) and HLA-DQ (Leu-10) (Becton Dickinson Monoclonal Center, Mountain View, CA, USA). All mAbs were used in an indirect immunofluorescence (IF) test with FITC-conjugated goat anti-mouse IgG or IgM (Cappel Laboratories). In addition to immunophenotyping the fresh leukemic cells, additional mAbs (Table 1) were used to type the established cell line.
Immunofluorescent positive cells were determined by fluorescence microscopy. CD9 (BA-2) was a gift from Dr TW LeBien (University of Minnesota, Minneapolis, MN, USA). CD14 (MY4), CD33 (MY9), and CD34 (MY10) were purchased from Coulter Immunology. CD15 (leu-M1) was purchased from Becton Dickinson. CD120A and CD120B were a gift from Dr WA Buurman (University of Limburg, Maastricht, The Netherlands). CD115 was obtained from Dr T Kishimoto (Osaka University Medicine III, Osaka, Japan) via the 6th International Workshop on Human Leukocyte Differentiation Antigens (HLDA). Remaining antibodies were obtained from Dr S Shaw (National Institutes of Health, Bethesda, MD, USA) via the 5th International Workshop on HLDA.
Southern blot analysis
Southern blot analysis was performed following established methods. 9 Briefly, genomic DNA was extracted in TNE buffer (10 mM Tris, pH 8.0, 100 mM NaCl, and 1 mM EDTA, pH 8.0) with 2 mg proteinase K and 1% SDS, and precipitated in absolute ethanol. The DNA pellets were dried and dissolved in TE buffer (10 mM Tris, pH 7.6, and 1 mM EDTA, pH 8.0), then digested with one of the following restriction enzymes EcoRI, BamHI, or HindIII (Takara Shuzo, Otsu, Japan) for 4 h at 37°C. Ten micrograms of digested DNA were loaded on a 0.8% agarose gel, electrophoresed, and transferred to nylon membranes (Hybond N; Amersham International, Buckinghamshire, UK) for 18 h at room temperature. The membranes were dried in a Gel Drying Processor AE-3700 (ATTO, Tokyo, Japan), and then prehybridized. Hybridization was conducted at 42°C in hybridization buffer (50% formamide, 0.5% SDS, 5× Denhardt solution 100 g/ml salmon sperm DNA) overnight. The membranes were sequentially washed twice with 2 × SSC, 0.1% SDS at room temperature for 15 min, and then 0.2 × SSC, 0.1% SDS at 42°C for 30 min; and, if necessary, 0.2 × SSC, 0.2% SDS at 55°C for 30 min. Autoradiography was performed using Biomax-MR film (Eastman Kodak, New Haven, CT, USA) at (−80°C). Exposure times ranged from overnight to 5 days. Probes were labeled with ␣-32 P-dCTP following the manufacturer's recommendations (Megaprime DNA Labeling Systems; Amersham). Three probes, IgJH, 10 C 11 and C, 12 were used to investigate the status of the Ig genes. DNA digested with BamHI, EcoRI or HindIII was hybridized with C, C or IgJH probes, respectively.
Western blot analysis
Western blotting was conducted as previously described by Kuwahara et al. 13 Briefly, the proteins were extracted in a buffer containing 0.5% NP-40, and separated in a 12.5% gel by SDS-PAGE. After blotting the proteins on to a nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany), the filter was blocked with 5% no-fat dry milk/PBS/0.1% Tween 20. It was then incubated with rabbit anti-human or antibody (Dako, Kyoto, Japan), washed with PBS/0.1% Tween 20 and reincubated with protein A-peroxidase (Zymed Laboratories, South San Francisco, CA, USA) for 60 min at room temperature. The filter was washed again with PBS/0.1% Tween 20 and the bands detected using the ECL Detection System (Amersham).
EBV infection
EBV infection was determined by PCR using EBV nuclear antigen (EBNA)-1 specific primers. In brief, DNA was extracted using an Iso-Quick DNA Extraction Kit (MicroProbe, Bothell, WA, USA). The oligonucleotide sequences specific to EBNA-1 reported by Ambinder et al 14 were synthesized with an Oligonucleotide DNA Synthesizer (model 394; Applied Biosystems, Foster, CA, USA). PCR was carried out using an Omnigen Automated Temperature Cycler (Hybaid, Middlesex, UK) for 30 cycles.
Cytogenetic analysis
Standard cytogenetic harvesting, preparation and staining procedures were used throughout. Briefly, mitotic cells were harvested by colcemid arrest (0.004 M for 2 h) and after hypotonic treatment with 0.075 M KCl and 0.9% NaCitrate (1:20 for 10 min), fixed in chilled methanol:acetic acid (3:1). Trypsin G-banding 15 was performed on slides after aging for 10 days. For G-banding, the slides were incubated briefly (15 s) in trypsin solution and stained for 15 min in 5% Giemsa in Sorensen's buffer (pH 6.8). Analysis was performed using a Zeiss Axioplan (Carl Zeiss, Oberkochen, Germany) microscope connected to an image-analysis system (Cytoscan 3; Applied Imaging, Warrington, UK) equipped with a highresolution laser printer (Lasertechnics, Tuscon, AZ, USA). The consensus karyotype was derived by analysis of 25 cells.
Determination of PHTrP
Reverse-transcriptase polymerase chain reaction (RT-PCR) was utilized for mRNA of PTHrP analysis following methods reported elsewhere. 16, 17 Total RNA was isolated from cell pellets using an Ultraspec RNA Isolation System (Biotecx Laboratories, Houston, TX, USA). One microgram of total RNA was used to synthesize the first strand cDNA applying RT preamplification using a random primer, 100 pmol in 30 l. The RT was carried out in a final volume of 30 l RT buffer (containing 50 mM Tris-HCl, pH 8.4, 75 mM KCl, 3 mM MgCl 2 , 0.1 mg/ml bovine serum albumin). The mixture was incubated at 65°C for 15 min; 200 U of Moloney murine leukemia virus RT, 1 l of 10 mM dNTP mix, 6.7 mM DTT and 20 U of RNase inhibitor were added to the reaction which was incubated at 37°C for 60 min. The reaction was stopped by heating to 90°C for 5 min and then quickly chilling on ice. Two microliters of the first strand cDNA (corresponding to 0.07 g of RNA) were diluted with PCR buffer (10 × 500 mM KCl, 15 mM MgCl 2 , 100 mM Tris-HCl pH 8.8, 0.01% gelatine) containing 30 pmol of each upstream and downstream primer, 15 nmol of dNTP mix and 1.5 U of Taq DNA polymerase (Perkin Elmer, Tokyo, Japan) for the PCR reaction. Primers were purchased from Biologica (Nagoya, Japan). The oligonucleotide sequences for the sense primer was: 5′-CTGGTTCAGCAGTGGAGCGTC-3′, and for the antisense primer was: 5′-GTTAGGGGACAC-CTCCGAGGT-3′ following the PTHrP protein sequence. To determine the quality of the RNA, RT reaction and PCR amplification, the followimg primers were used to amplify HGPRT: sense (5′-GCGTCGTGATTAGTGATGATGAACCA-3′) and antisense (5′-CTTGAGCACACAGAGGGCTACAAT-3′). The PCR reaction for PTHrP was carried out using an Omnigen Automated Temperature Cycler (Hybaid) under the following conditions: denaturation for 1 min at 94°C, annealing for 1 min at 64°C, extension for 1 min at 72°C for 35 cycles. The PCR product (10 l) was electrophoresed on an ethidium bromide-stained 1.5% agarose gel and observed under UV light.
Quantitation of PTHrP in both the patient's serum and the culture supernatant of the established cell line was carried out by immunoradiometric assay as reported elsewhere. 18 In order to measure the PTHrP level of the culture supernatant, a onestep cell growth experiment was set up. The BALM-16 cells were counted daily until cell growth went into decline. One milliliter of culture supernatant was harvested daily, spun down at 700 g, and filtered using a 0.2 m filter (Millipore Millex-GV; Millipore, Tokyo, Japan). The samples were kept at −80°C until measurement.
Results
Establishment of cell line
Peripheral blood mononuclear cells obtained from the patient were cultured as described in the Materials and methods. The cells were maintained without any feeder cells or growth factors. The first subculture was made 3 weeks after the culture was started. The cells proliferated consistently as free-floating suspensions. When established, the cell line was designated BALM-16 ( Figure 2 ). In one-step cell growth curve measure-
Figure 2
Wright-Giemsa staining of BALM-16 cells showing fine nuclear chromatin networks with prominent nucleoli, some vacuoles are also seen (original magnification × 310).
ments, when initial cell densities were adjusted to 1 × 10 5 cells/ml, the maximum cell density of BALM-16 was 2.6 × 10 6 cell/ml with a doubling time of 32 h. BALM-16 was negative for EBV infection by PCR with primers specific for EBNA-1.
Cell surface markers
The cell surface marker profile of the BALM-16 cell line is summarized in Table 1 , along with comparable data for the fresh leukemia cells. The percentage of immunofluorescence positive cells was calculated by immunofluorescence microscopy: mean values obtained from more than three tests are shown in Table 1 . When immunophenotyping of the fresh leukemia cells was carried out, neither cell surface nor cytoplasmic Ig chains were detected. Ig L chains for and and the H chain were further analyzed by Western blotting, using polyclonal antibodies; however, no bands were obtained, confirming the results obtained by immunophenotyping.
B cell-associated CD antigens were detected in both the cell line and in the fresh leukemia cells; but none of the T cell or myeloid antigens were expressed. BALM-16 and the fresh leukemia sample were both found to be positive for HLA-class I and II antigens.
Cytogenetic analysis
The complete karyotype of stemline cells of BALM-16 showed 47, Ͻ2nϾ, XY, t(1;4)(q32.2;q35), t(8;22)(q24;q11), add(11) (q13), del(13)(q13q14.2), +18 (Figure 3a) . 
Southern blot analysis
Southern blot analysis was performed to determine whether the Ig genes of DNA from different stages of passage of BALM-16 were rearranged. Both preparations of BALM-16 showed the same pattern for the JH, C, and C genes. They showed homozygous rearrangement and deletion patterns for the JH gene and C genes, respectively. CCRF-CEM, a T cell line, was used as a germ line control and ARH-77, a myeloma cell line, was used as a control for rearrangement of the JH and C genes. Comparison with BALL-1, a B cell line used as a positive control for rearrangement of the C gene, revealed a germ line configuration for this gene in BALM-16 ( Figure 4 ).
PTHrP
Using a specific primer to amplify PTHrP, a postive band at 231 bp was found in both preparations of BALM-16. The cell lines, LoVo (colon cancer), U-266 and RPMI-8226 (both multiple myeloma) were used as positive controls, both showing a clear band at 231 bp. In MOLT-4 (T cell leukemia), a positive band was unexpectedly obtained, and a weak but positive band was also obtained from HL-60 (myelocytic leukemia). Raji (Burkitt lymphoma) was found to be negative for PTHrP ( Figure 5 ).
Quantitation of PTHrP using the harvested culture supernatant from BALM-16 revealed that its value was within the normal range (Ͻ1.1 pmol/l). 
Discussion
We describe here a novel leukemia cell line, BALM-16, derived from the peripheral blood of a patient with ALL-L3, uniquely lacking expression of both cytoplasmic and cell surface Ig chains. When we performed immunophenotyping of the fresh leukemia cells, less than 10% were positive for Ig chains among more than 90% leukemic blasts. Although, there was no unequivocal evidence whether the 10% Ig positive cell population actually represented leukemic blast, or residual normal, cell populations, the latter seems more likely. Indeed, expression of Ig chains in BALM-16 was completely undetectable.
Southern blot analysis of the Ig genes provided strong evidence that BALM-16 was of B cell origin. The IgH gene pattern observed in the cell line was homozygous at both loci; the C gene was deleted at both alleles, while the C gene was found to display a germline configuration.
B cell malignancies are considered to be monoclonal proliferations of Ig positive cells and such tumors are believed to express a single L and H chain isotype on the cell surface. However, exceptionally, the expression of a double L chain isotype has been reported in certain leukemia/lymphoma cases. 8, 9, [19] [20] [21] Moreover, using the technique of EBV transformation, the existence of double L chain positive cell populations has been demonstrated in fetal bone marrow and spleen. 19, 20 According to a report by Giachino et al 21 a small (Ͻ1%), yet significant number, of double L chain positive cells was also detectable in the peripheral blood of healthy volunteers. They suggested that double L chain positivity may be a transient stage of B cell maturation as evidenced by the process of switching L chain isotypes. The possibility of isotype switching in the --pathway was suggested by Gollahon et al 22 and Hardy et al. 23 We 9 previously reported for subclones with distinct immunoglobulin light chain phenotypes ( ALL-L3, especially Burkitt lymphoma, is subdivided into two groups namely group I and III, 24 Table 1 , the immunophenotyping of the cell line clearly showed a B cell pattern with positivity for CD9, CD10, CD19, cytoplasmic CD22, CD24, CD39, CD40, CD72, CD76, cytoplasmic CD79b, NU-B1 and HLA-class II antigens. The T cell-associated CD antigens and myeloid-associated CD antigens tested were negative.
That BALM-16 is positive for PTHrP mRNA is a further striking finding, and could be the reason for the transient hypercalcemia, offering an explanation for the decreasing levels of calcium after chemotherapy with a subsequent increase accompanying leukemic progression. However, the culture supernatant from the cell line was found to be negative for PTHrP production. The cause of this remains unknown, and the following explanations are proposed: (1) loss of post-translational negative feedback control related to PTHrP production had occurred in the leukemic clone giving rise to the cell line; (2) in order to produce PTHrP, the cells might need some additional stimuli such as from cytokines or chemicals. The production of PTHrP in hematopoietic malignancies has been reported, 17, [25] [26] [27] [28] however, there have been few cases among B cell malignancies. 28 In any event, this report is the first to our knowledge to describe a cell line with the unique set of characteristics, including freedom from EBV infection and an ALL-L3 origin, yet lacking expression of Ig chains carring PTHrP mRNA. This cell line could be useful in studying the pathogenesis of ALL-L3 cases carrying the cytogenetic abnormality t(8;22)(q24;q11). This translocation deregulates the C-MYC oncogene at 8q24 by juxtaposing it with the Ig L-chain locus at chromosome 22q11. The breakpoint in chromosome 8q24 occurs immediately 3′ of (or distal to) C-MYC which fuses head-to-tail with the translocation Ig L-chain gene. However, the relevance of this rearrangement to the absent expression of Ig chains in the present case is unclear, as several instances of the same cytogenetic abnormality together with monoclonal Ig chain expression have been described. [29] [30] [31] [32] The karyotype of BALM-16, 47Ͻ2nϾXY, t(1;4)(q32.2;q35), t(8;22)(q24;q11), del(13)(q13q14.2), +18, closely resembled that of the abnormal clone analyzed in the bone marrow at first relapse. It is possible that the del(13q) arose de novo during cell culture, or that it was already present in a subclone which expanded at second relapse or during the subsequent establishment of the cell line. Although there have been only few cases of del(13q) in ALL, this deletion is a recurrent change in chronic B cell disorders. 33 Similarly, trisomy 18 is a recurrent contributor to hyperdiploidy in ALL. In addition, although t(1;4)(q32;q35) has not been previously reported in ALL, the 1q32 breakpoint involved is recurrent in L3 ALL. 33 Taken together, these findings show that BALM-16 faithfully models recurrent cytogenetic features of B cell ALL.
In summary, BALM-16 may provide a useful material for analyzing both the mechanism of PTHrP production and signalling during B cell development.
